Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shinsuke Iida

Showing results (21-30 of 328) with videos related to

Pageof 33
Sort By:
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|June 8, 2018
[Multiple myeloma: update on pathophysiology and management]Ichiro Hanamura, Shinsuke Iida
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|September 6, 2013
[Myeloma therapy (3) Trends in development of new drugs]Masaki Ri, Shinsuke Iida
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|April 1, 2014
[Determinants of sensitivity to proteasome inhibitors and strategies to overcome acquired resistance to bortezomib in multiple myeloma]Shinsuke Iida, Masaki Ri
Yakugaku Zasshi : Journal of the Pharmaceutical Society of Japan|May 8, 2015
[Development of mogamulizumab and establishment of an optimal therapy based on genomic biomarkers: from the academic viewpoint]Shinsuke Iida, Takashi Ishida, Ryuzo Ueda
International Journal of Hematology|April 10, 2019
JSH practical guidelines for hematological malignancies, 2018: III. Myeloma-2. Related disorders of multiple myelomaShinsuke Iida, Chihiro Shimazaki, Masahiro Abe, et al.
Haematologica|January 19, 2007
Induction of class II major histocompatibility complex expression in human multiple myeloma cells by retinoidTakaomi Sanda, Shinsuke Iida, Satoshi Kayukawa, et al.
Japanese Journal of Clinical Oncology|July 13, 2022
Recent advances in the management of older adults with newly diagnosed multiple myeloma in JapanTomotaka Suzuki, Dai Maruyama, Shinsuke Iida, et al.
Japanese Journal of Cancer Research : Gann|May 3, 2002
Lack of Ku80 alteration in multiple myelomaMiyuki Kato, Shinsuke Iida, Hirokazu Komatsu, et al.
International Journal of Hematology|March 10, 2015
Phase I study of pegylated liposomal doxorubicin in combination with bortezomib for Japanese patients with relapsed or refractory multiple myelomaShigeru Kusumoto, Kazutaka Sunami, Mitsuo Inagaki, et al.
Blood Cancer Journal|March 22, 2023
Clinical evidence for immune-based strategies in early-line multiple myeloma: current challenges in decision-making for subsequent therapyNoopur Raje, María-Victoria Mateos, Shinsuke Iida, et al.
Pageof 33

Showing results (21-30 of 328) with videos related to

Sort By:
Pageof 33
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|June 8, 2018
[Multiple myeloma: update on pathophysiology and management]Ichiro Hanamura, Shinsuke Iida
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|September 6, 2013
[Myeloma therapy (3) Trends in development of new drugs]Masaki Ri, Shinsuke Iida
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|April 1, 2014
[Determinants of sensitivity to proteasome inhibitors and strategies to overcome acquired resistance to bortezomib in multiple myeloma]Shinsuke Iida, Masaki Ri
Yakugaku Zasshi : Journal of the Pharmaceutical Society of Japan|May 8, 2015
[Development of mogamulizumab and establishment of an optimal therapy based on genomic biomarkers: from the academic viewpoint]Shinsuke Iida, Takashi Ishida, Ryuzo Ueda
International Journal of Hematology|April 10, 2019
JSH practical guidelines for hematological malignancies, 2018: III. Myeloma-2. Related disorders of multiple myelomaShinsuke Iida, Chihiro Shimazaki, Masahiro Abe, et al.
Haematologica|January 19, 2007
Induction of class II major histocompatibility complex expression in human multiple myeloma cells by retinoidTakaomi Sanda, Shinsuke Iida, Satoshi Kayukawa, et al.
Japanese Journal of Clinical Oncology|July 13, 2022
Recent advances in the management of older adults with newly diagnosed multiple myeloma in JapanTomotaka Suzuki, Dai Maruyama, Shinsuke Iida, et al.
Japanese Journal of Cancer Research : Gann|May 3, 2002
Lack of Ku80 alteration in multiple myelomaMiyuki Kato, Shinsuke Iida, Hirokazu Komatsu, et al.
International Journal of Hematology|March 10, 2015
Phase I study of pegylated liposomal doxorubicin in combination with bortezomib for Japanese patients with relapsed or refractory multiple myelomaShigeru Kusumoto, Kazutaka Sunami, Mitsuo Inagaki, et al.
Blood Cancer Journal|March 22, 2023
Clinical evidence for immune-based strategies in early-line multiple myeloma: current challenges in decision-making for subsequent therapyNoopur Raje, María-Victoria Mateos, Shinsuke Iida, et al.
Pageof 33